Glenmede Trust’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$246K Buy
2,640
+30
+1% +$2.66K ﹤0.01% 1229
2025
Q4
$210K Buy
+2,610
New +$219K ﹤0.01% 1268
2024
Q4
Sell
-5,538
Closed -$581K 1385
2024
Q3
$581K Buy
5,538
+790
+17% +$92.4K ﹤0.01% 888
2024
Q2
$675K Buy
+4,748
New +$547K ﹤0.01% 802
2023
Q4
Sell
-8,038
Closed -$1.31M 1298
2023
Q3
$1.31M Buy
+8,038
New +$1.41M 0.01% 600
2020
Q4
Sell
-884
Closed -$19K 1202
2020
Q3
$19K Sell
884
-71
-7% -$1.81K ﹤0.01% 1634
2020
Q2
$26K Buy
955
+716
+300% +$17.5K ﹤0.01% 1491
2020
Q1
$5K Hold
239
﹤0.01% 2661
2019
Q4
$5K Sell
239
-88
-27% -$1.85K ﹤0.01% 2661
2019
Q3
$5 Buy
327
+95
+41% +$1.52K ﹤0.01% 2610
2019
Q2
$3 Hold
232
﹤0.01% 2733
2019
Q1
$4 Hold
232
﹤0.01% 2652
2018
Q4
$4 Buy
+232
New +$4.12K ﹤0.01% 2585
2017
Q4
Sell
-6,706
Closed -$183K 2661
2017
Q3
$183K Buy
+6,706
New +$148K ﹤0.01% 1256
2016
Q2
Sell
-193
Closed -$1K 2544
2016
Q1
$1K Hold
193
﹤0.01% 2477
2015
Q4
$1K Buy
193
+146
+311% +$1.55K ﹤0.01% 2534
2015
Q3
$0 Buy
+47
New +$573 ﹤0.01% 2702
2014
Q2
Sell
-5,171
Closed -$44K 2316
2014
Q1
$44K Sell
5,171
-5,250
-50% -$48.3K ﹤0.01% 1671
2013
Q4
$101K Sell
10,421
-1,838
-15% -$16.7K ﹤0.01% 1398
2013
Q3
$103K Buy
12,259
+4,233
+53% +$34.3K ﹤0.01% 1362
2013
Q2
$58K Buy
+8,026
New +$46.6K ﹤0.01% 1480

Other funds holding ACLS

Glenmede Trust's ACLS Position: Q1 2026 in Review

Glenmede Trust increased its Axcelis (ACLS) stake by 1.1% in Q1 2026, buying an estimated $2.66K and bringing the position to 2,640 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #1229.

Glenmede Trust first reported a position in ACLS in Q2 2013 and has held it in 21 quarters since. The position peaked at $1.31M in Q3 2023. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Glenmede Trust held 2,640 shares of Axcelis worth $246K as of Q1 2026.
  • Glenmede Trust bought 30 Axcelis shares in Q1 2026, an estimated $2.66K.
  • Axcelis made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2026, its #1229 holding.
  • Glenmede Trust first reported a position in Axcelis in Q2 2013 and has held it in 21 quarters since.
  • Glenmede Trust's Axcelis position peaked at $1.31M in Q3 2023.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.